Back

Cavin-1 regulates BMP/Smad signaling through the interaction of Caveolin-1 with BMPRII in pulmonary artery endothelial cells

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Basic Science Vascular ePosters Hypertension, Pulmonary Hypertension ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Shinya Tomita

Kyoto Prefectural University of Medicine, Kyoto (Japan)

51 More presentations in this session

Presentation thumbnail
Human adventitial pericytes secrete bioactive factors exerting distinct biological effects on cardiac cells: hints for cardiac repair
Doctor E. Avolio (Bristol, GB)
Abstract Slides
Presentation thumbnail
Mechanisms of endothelial cell activation by endocannabinoid 2-arachidonoylglycerol
Doctor J. Jehle (Bonn, DE)
Abstract Slides
Presentation thumbnail
A novel senolytic drug, seno-7284 ameliorates aging phenotype and age-related cardiometabolic diseases
Doctor G. Katsuumi (Tokyo, JP)
Abstract Slides
Presentation thumbnail
iPSC-derived endothelial cells reflect accelerated senescence and increased inflammatory response in a CVD-risk stratified manner
Doctor E. Straessler (Berlin, DE)
Abstract Slides
Presentation thumbnail
Blocking of interleukin-1 suppresses both angiotensin II-induced renal inflammation and hypertension
Doctor T. Niida (Tokyo, JP)
Abstract Slides

Access the full session

Session thumbnail
Basic Science Vascular ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Inhibin Beta-A is a novel gene involved in the development of pulmonary arterial hypertension through inhibiting BMPRII-signaling in endothelial cells
3 September 2019
thumbnail
Congress Presentation
Caveolin-dependent endocytosis regulates arterial calcification
13 April 2024
thumbnail
Congress Presentation
N-cadherin promotes cardiac regeneration by stabilizing beta-catenin
3 September 2019
thumbnail
Congress Presentation
Proteomics profiling reveals signaling pathways associated with major adverse cardiovascular events in patients with hypertrophic cardiomyopathy
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources